Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Combining scalp cooling with a special lotion helps prevent severe hair loss in breast cancer patients undergoing chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Botanical lotion CG428 may help regrow hair and reduce scalp inflammation in chemotherapy patients.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Combining immune checkpoint inhibitors with other cancer therapies increases skin side effects in Asian patients.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

The compound 4c showed strong potential as an anticancer agent.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Ayurvedic treatment may improve quality of life for cancer patients undergoing chemo and radiotherapy.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Home health occupational therapy should be included before chemotherapy to improve patient care.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

The conclusion is unclear about minoxidil's effectiveness for preventing hair loss from chemotherapy.